IN DEPTH Narrow FDA vote on Merck’s molnupiravir bolsters outlook on mAbs Can drug repurposing uncover better treatments for UTIs? Lethal injection: can pharma kill the death penalty? Pharmacovigilance The challenges of multiple drugs safety reporting Safety reporting for treatments involving multiple drugs must improve to protect patients from harmful drug-drug interactions PRICNG Pfizer and Takeda deals put a spotlight on value-based pricing MANUFACTURING 3D printing in drug manufacturing: unlocking future possibilities Narrow FDA vote on Merck’s molnupiravir bolsters outlook on mAbs Can drug repurposing uncover better treatments for UTIs? Lethal injection: can pharma kill the death penalty? 02/24/2024 03:29:02
Narrow FDA vote on Merck’s molnupiravir bolsters outlook on mAbs
Can drug repurposing uncover better treatments for UTIs?
Lethal injection: can pharma kill the death penalty?